Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel

Reshma Mahtani

Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Advances in Therapy
Volume	40
State	Published - Jan 1 2023

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel. / Mahtani, Reshma.
In: Advances in Therapy, Vol. 40, 01.01.2023.

Research output: Contribution to journal › Article › peer-review

@article{9a657da4ae0141fcbe9d9c2889c5e590,

title = "Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel",

author = "Reshma Mahtani",

note = "Advances in Therapy (2022) 40(1):331-348",

year = "2023",

month = jan,

day = "1",

language = "American English",

volume = "40",

journal = "Advances in Therapy",

}

TY - JOUR

T1 - Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel

AU - Mahtani, Reshma

N1 - Advances in Therapy (2022) 40(1):331-348

PY - 2023/1/1

Y1 - 2023/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4573

M3 - Article

VL - 40

JO - Advances in Therapy

JF - Advances in Therapy

ER -

Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel

Access to Document

Other files and links

Cite this